Bio-Rad Laboratories 

$309.37
117
+$10.87+3.64% Monday 15:55

統計

當日最高
309.37
當日最低
309.37
52週高點
321.12
52週低點
244.54
成交量
91
平均成交量
116
市值
6.71B
本益比
49.75
股息殖利率
-
股息
-

即將到來

財報

30Jul預期
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
下一步
1.73
2.12
2.51
2.9
預期EPS
1.747616
實際EPS
不適用

財務

-71.86%利潤率
未盈利
2019
2020
2021
2022
2023
2024
2.57B營收
-1.84B淨利

分析師評級

303.33平均目標價
最高預估為 320.00。
來自過去6個月內的 3 則評分。這不是投資建議。
買入
33%
持有
67%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 BIO-B 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Bio-Rad Laboratories, Inc. creates, manufactures, and markets products essential for life science research and clinical diagnostics. Its operations span globally, covering territories such as the United States, Europe, Asia, Canada, and Latin America. The company's business is organized into two main divisions: Life Science and Clinical Diagnostics. The Life Science division develops and provides a comprehensive array of reagents, laboratory apparatus, and instruments. These are vital for various applications, including scientific research methodologies, biopharmaceutical production processes, and food quality testing. This segment dedicates its efforts to key areas within the life sciences, such as proteomics, genomics, biopharmaceutical development, cellular biology, and ensuring food safety. Its diverse clientele includes academic institutions (universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology researchers, and both food producers and testing laboratories. Conversely, the Clinical Diagnostics division specializes in designing, producing, selling, and supporting diagnostic test systems, informatics solutions, test kits, and specific quality control measures for clinical laboratories. This segment furnishes reagents, instrumentation, and software precisely tailored to address particular requirements within the in vitro diagnostics market. Its products are utilized by reference laboratories, hospital labs, state-operated newborn screening facilities, physicians' private offices, and blood transfusion centers. Furthermore, Bio-Rad offers systems and products designed for separating intricate chemical and biological substances, as well as for identifying, analyzing, and purifying their individual components. The company distributes its offerings through a multi-channel approach, leveraging both its direct sales force and a network of distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was established in 1952 and its corporate headquarters are located in Hercules, California.
Show more...
執行長
Mr. Norman D. Schwartz
員工
7700
國家
美國
ISIN
US0905721082

上市

0 Comments

分享你的想法

FAQ

Bio-Rad Laboratories 今天的股價是多少?
BIO-B 目前價格為 $309.37 USD,過去 24 小時上漲了 +3.64%。在圖表上更密切關注 Bio-Rad Laboratories 股價表現。
Bio-Rad Laboratories 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 XNYS 交易所,Bio-Rad Laboratories 的股票以代號 BIO-B 進行交易。
Bio-Rad Laboratories 的市值是多少?
今天 Bio-Rad Laboratories 的市值為 6.71B
Bio-Rad Laboratories 下一次財報日期是什麼時候?
Bio-Rad Laboratories 將於 July 30, 2026 公布下一次財報。
Bio-Rad Laboratories 上一季度的財報如何?
BIO-B 上一季度的財報為每股 1.89 USD,預估為 1.97 USD,帶來 -4.21% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Bio-Rad Laboratories 去年的營收是多少?
Bio-Rad Laboratories 去年的營收為 2.57BUSD。
Bio-Rad Laboratories 去年的淨利是多少?
BIO-B 去年的淨收益為 -1.84BUSD。
Bio-Rad Laboratories 有多少名員工?
截至 July 18, 2026,公司共有 7,700 名員工。
Bio-Rad Laboratories 位於哪個產業?
Bio-Rad Laboratories從事於Health & Wellness產業。
Bio-Rad Laboratories 何時完成拆股?
Bio-Rad Laboratories 最近沒有進行任何拆股。
Bio-Rad Laboratories 的總部在哪裡?
Bio-Rad Laboratories 的總部位於 美國 的 Hercules。